Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Intestinal transit-amplifying cells require METTL3 for growth factor signaling and cell survival
Charles H. Danan, Kaitlyn E. Naughton, Katharina E. Hayer, Sangeevan Vellappan, Emily A. McMillan, Yusen Zhou, Rina Matsuda, Shaneice K. Nettleford, Kay Katada, Louis R. Parham, Xianghui Ma, Afrah Chowdhury, Benjamin J. Wilkins, Premal Shah, Matthew D. Weitzman, Kathryn E. Hamilton
Charles H. Danan, Kaitlyn E. Naughton, Katharina E. Hayer, Sangeevan Vellappan, Emily A. McMillan, Yusen Zhou, Rina Matsuda, Shaneice K. Nettleford, Kay Katada, Louis R. Parham, Xianghui Ma, Afrah Chowdhury, Benjamin J. Wilkins, Premal Shah, Matthew D. Weitzman, Kathryn E. Hamilton
View: Text | PDF
Research Article Gastroenterology

Intestinal transit-amplifying cells require METTL3 for growth factor signaling and cell survival

  • Text
  • PDF
Abstract

Intestinal epithelial transit-amplifying cells are essential stem progenitors required for intestinal homeostasis, but their rapid proliferation renders them vulnerable to DNA damage from radiation and chemotherapy. Despite these cells’ critical roles in intestinal homeostasis and disease, few studies have described genes that are essential to transit-amplifying cell function. We report that RNA methyltransferase-like 3 (METTL3) is required for survival of transit-amplifying cells in the murine small intestine. Transit-amplifying cell death after METTL3 deletion was associated with crypt and villus atrophy, loss of absorptive enterocytes, and uniform wasting and death in METTL3-depleted mice. Sequencing of polysome-bound and methylated RNAs in enteroids and in vivo demonstrated decreased translation of hundreds of methylated transcripts after METTL3 deletion, particularly transcripts involved in growth factor signal transduction such as Kras. Further investigation verified a relationship between METTL3 and Kras methylation and protein levels in vivo. Our study identifies METTL3 as an essential factor supporting the homeostasis of small intestinal tissue via direct maintenance of transit-amplifying cell survival. We highlight the crucial role of RNA modifications in regulating growth factor signaling in the intestine with important implications for both homeostatic tissue renewal and epithelial regeneration.

Authors

Charles H. Danan, Kaitlyn E. Naughton, Katharina E. Hayer, Sangeevan Vellappan, Emily A. McMillan, Yusen Zhou, Rina Matsuda, Shaneice K. Nettleford, Kay Katada, Louis R. Parham, Xianghui Ma, Afrah Chowdhury, Benjamin J. Wilkins, Premal Shah, Matthew D. Weitzman, Kathryn E. Hamilton

×

Figure 7

METTL3 deletion downregulates KRAS and induces cellular senescence.

Options: View larger image (or click on image) Download as PowerPoint
METTL3 deletion downregulates KRAS and induces cellular senescence.
(A) ...
(A) Integrated Genomics Viewer depiction of read density for m6A-RIP (red) and input RNA (blue) for the Kras transcript as determined by m6A-seq in distal small intestinal crypts of n = 3 wild-type mice. CDS, coding sequence; RIP, RNA immunoprecipitation. (B–E) m6A enrichment determined by m6A-RIP-qPCR with primers targeting Kras 5′ UTR, CDS exons 1–2, CDS exons 3–4A, and 3′ UTR in crypt-enriched lysates from Mettl3fl/fl and Mettl3VilCreERΔ/Δ mice 3 days posttamoxifen. Data presented as mean ± SD. Dotted line at m6A enrichment = 1. (F) qPCR for Kras transcript in crypt-enriched lysates from Mettl3fl/fl and Mettl3VilCreERΔ/Δ mice 3 days posttamoxifen. Data normalized to Actb and the mean of Mettl3fl/fl controls. Data presented as mean ± SD. (G) Western blot for top targets with downregulated TE in crypts of Mettl3fl/fl and Mettl3VilCreERΔ/Δ mice 2 days after final tamoxifen injection (n = 2 mice per genotype). (H) Representative images and quantification of p-ERK staining in atrophic small intestinal crypts in Mettl3VilCreERΔ/Δ mice and region-matched Mettl3fl/fl controls 9 days after final tamoxifen injection. “p-ERK low” crypts contain < 5 p-ERK+ cells. (I–K) Representative images and quantification of p21, γH2AX, and β-galactosidase staining in distal half small intestine of Mettl3fl/fl and Mettl3VilCreERΔ/Δ mice 2 days after final tamoxifen injection. (L) β-Galactosidase staining in control VilCreERT2 and Mettl3VilCreERΔ/Δ enteroids 3 days after 4-OHT. For all plots, each data point represents a single mouse, and P denotes value of unpaired parametric Student’s t test. Unless otherwise noted, immunofluorescence data are from areas of most severe histological distortion in distal small intestine of mice 2 days after final tamoxifen injection. For immunofluorescence, each data point is the mean of 3 representative sections imaged per mouse with bars at median value. Scale bar 100 μm.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts